In addition, mutations in U2 small nuclear RNA auxiliary factor 1 (U2AF1) or Wilms’ tumor suppressor gene 1 (WT1) are associated with poor survival of patients with AML and myelodysplastic syndromes [41–43]. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.